The following below contents do not contain the full and detailed information of the Decree 54/2017/ND-CP and the Decree 155/2018/ND-CP , but the information is extracted and summarized briefly as a part of the Decrees on measures for drug price management in Vietnam.
Every pharmacy business establishment shall implement regulations on the declaration and re-declaration of drug prices, other regulations on drug pricing of this Decree and relevant legislative documents; take legal responsibility for the declared and re-declared prices, accuracy of the reports and information provided.
A pharmacy business establishment may sell a drug from the date on which its price is declared or re-declared by the manufacturer, outsourcing entity or importer.
A pharmacy business establishment must not sell a drug wholesale or retail at a price higher than the price declared or re-declared by the manufacturer, outsourcing entity or importer.
Drug pricing authorities shall establish a Drug Pricing Department to review the accuracy of the declared and re-declared drug prices.
Declared/re-declared drug prices shall be reviewed on the following basis:
Responsibility to list drug price:
Price listing:
The retail price equals (=) buying price according to the invoice plus (+) the retail margin percent rate multiplied by (x) buying price. Formula:
Retail price equals = buying price + retail margin percent (%) x buying price |
The drug retailer within the premises of a health facility may only buy drugs from suppliers that are awarded contracts for supplying drugs to such health facility and drugs selected at the health facilities in provinces and central-affiliated cities within 12 months; drugs selected and procured in localities and nationwide within the term of the contract or the centralized procurement framework before the procurement. The buying prices are specified below:
This regulation does not apply to drugs that are licensed for import according to Articles 67 and 68 of Decree No. 54/2017/ND-CP; narcotic drugs, psychotropic drugs, precursor drugs and new drugs according to clause 14, Article 2 of the Law on Pharmacy. Such drugs are not supplied by successful bidders of the health facilities.
Maximum retail margin percents applied to drug retailers in health facilities:
The purchase price calculated on the smallest packaging unit | Maximum retail margin percent |
Not exceeding 1,000 VND | 15% |
Exceeding VND 1,000 but not exceeding VND 5,000 | 10% |
Exceeding VND 5,000 but not exceeding VND 100,000 | 7% |
Exceeding VND 100,000 but not exceeding VND 1,000,000 | 5% |
Exceeding VND 1,000,000 | 2% |
Definitions of the smallest pack:
Dosage form | Smallest pack |
Tablets, pills or capsules | A tablet, pill or capsule |
Liquid | A pre-filled tube, bottle, jar or syringe |
Powder for solution for injection | A pre-filled tube, bottle, jar, bag, or syringe |
Orally administered powder or granules | A bag or bottle |
Cream, salve or gel for topical administration | A tube or jar |
Transdermal patch | A patch |
Aerosol | A bottle |
Kit | A kit |
Bidding for drug purchases from state capital, health insurance fund, revenue from the provision of medical services and other lawful sources of revenue of public health facilities shall comply with regulations of law on bidding, the principles in Clause 4 Article 7 and Clause 6 Article 107 of the Law on Pharmacy.
The Minister of Health shall promulgate the list of drugs and herbal ingredients eligible for price negotiation according to Clause 6 Article 107 of herbal ingredients based on counsel of the National Advisory Council for Drug Bidding.
Regulations of the Law on Pricing and its instructional documents shall apply to the implementation of measures for drug price stabilization, power responsibility to implement of measures for drug price stabilization.